Arcutis Biotherapeutics 

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$30,858
$49,569
$13,526
$38,109
Gross Profit
27,394
46,313
11,082
36,927
EBITDA
-49,726
-31,264
-60,784
-34,183
EBIT
-50,077
-31,307
-61,169
-34,570
Net Income
-52,332
-35,382
-66,284
-44,765
Net Change In Cash
30,858
49,569
13,526
38,109
Free Cash Flow
-45,119
-31,603
-56,250
-44,048
Cash
84,887
190,714
89,323
107,471
Basic Shares
123,480
111,048
92,580
61,727

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$59,606
$3,686
$0
$0
Gross Profit
53,488
2,932
-763
-455
EBITDA
-239,220
-295,806
-206,075
-136,523
EBIT
-241,101
-297,059
-206,529
-136,978
Net Income
-262,140
-321,289
-205,902
-135,678
Net Change In Cash
59,606
3,686
0
0
Cost of Revenue
31,367
3,288
Free Cash Flow
-247,485
-280,998
-175,622
-113,354
Cash
89,323
53,641
96,449
65,082
Basic Shares
69,305
55,032
49,405
35,668

Earnings Calls

Quarter EPS
2024-06-30
-$0.42
2024-03-31
-$0.32
2023-12-31
-$0.72
2023-09-30
-$0.73